These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3. Gunness-Hey M, Hock JM, Gera I, Fonseca J, Poser J, Bevan J, Raisz LG. Calcif Tissue Int; 1986 Apr; 38(4):234-8. PubMed ID: 3085902 [Abstract] [Full Text] [Related]
18. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism]. Matuszkiewicz-Rowińska J, Niemczyk S, Przedlacki J, Puka J, Switalski M, Ostrowski K. Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839 [Abstract] [Full Text] [Related]
19. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. Civitelli R, Gonnelli S, Zacchei F, Bigazzi S, Vattimo A, Avioli LV, Gennari C. J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626 [Abstract] [Full Text] [Related]
20. Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study. Mazzuoli GF, Passeri M, Gennari C, Minisola S, Antonelli R, Valtorta C, Palummeri E, Cervellin GF, Gonnelli S, Francini G. Calcif Tissue Int; 1986 Jan; 38(1):3-8. PubMed ID: 3079649 [Abstract] [Full Text] [Related] Page: [Next] [New Search]